Targeting EHMT2 enhances NK cell maturation and antitumor activity
Minghang Yu, Xinhua Liu, Wenxiu Zhang, Xuefeng Huang, Yue Wu, Xinying Wang, Yuanyuan Chen, Ning Ding, Zilong Zhao, Xi Wang, Yang Li · 2026
Read Targeting EHMT2 enhances NK cell maturation and antitumor activity by Minghang Yu, Xinhua Liu, Wenxiu Zhang, Xuefeng Huang, Yue Wu, Xinying Wang, Yuanyuan Chen, Ning Ding, Zilong Zhao, Xi Wang, Yang Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13594311.txt.
Description
Minghang Yu and colleagues identify EHMT2, an enzyme that tags DNA-packaging proteins with a repressive mark, as a brake on the maturation of natural killer cells, the immune system's front-line tumor killers. Their 2026 study links the enzyme's level to weaker killer function across human tissues and cancers.
Deleting the gene only in mouse natural killer cells pushed the cells to full maturity, raising their output of interferon-gamma and their killing power in dishes and in living animals. Combined gene and mark profiling showed the loss lifted repression from whole programs for development and attack. Drugs blocking the enzyme copied these effects in human killer cells grown from cord blood stem cells and in cells from adult blood. The authors propose EHMT2 blockade as a way to sharpen cell-based cancer immunotherapy.
Catalog record
| CREATOR | Minghang Yu, Xinhua Liu, Wenxiu Zhang, Xuefeng Huang, Yue Wu, Xinying Wang, Yuanyuan Chen, Ning Ding, Zilong Zhao, Xi Wang, Yang Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50008 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |